Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris (RGPIRIS_PA)
Primary Purpose
Low Vision
Status
Terminated
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Scleral contact lens without a passive artificial iris
Scleral contact lens with a passive artificial iris with low contrast (<1:5)
Scleral contact lens with a passive artificial iris with high contrast (>1:5)
Tropicamide and phenylephrine
Sponsored by
About this trial
This is an interventional treatment trial for Low Vision focused on measuring visual acuity, contrast sensitivity, scleral contact lens, artificial iris
Eligibility Criteria
Inclusion Criteria:
- Age between 18 and 45 years old
Exclusion Criteria:
- Iris disorders (i.e. ocular albinism, coloboma, aniridia).
- Known disease-related ocular surface problem (i.e. microbial keratitis).
- Known ocular pathologies (except refractive disorders).
- Coexistent ocular diseases impeding contact lens correction (i.e. glaucoma, previous ocular surgery).
- Corneal scarring.
- Low corneal endothelial cell count (< 1500 cells per mm2), with potential of corneal hypoxia-induced corneal edema induced by contact lens wear.
- Wearing of contact lenses in the last 24 hours (prior to the interventions).
Sites / Locations
- University Hospital Ghent (UZGent)
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Healthy volunteers
Arm Description
15 healthy volunteers for trials with passive artificial iris
Outcomes
Primary Outcome Measures
Visual acuity assessment and comparison between Designs A, B and C by means of logMAR or equivalent value
Compare visual acuity values obtained with different designs
Contrast sensitivity assessment and comparison between Designs A, B and C by means of threshold percentage or equivalent value
Compare contrast sensitivity values obtained with different designs
Secondary Outcome Measures
Device safety by comparing eventual adverse events with those found in scleral contact lenses
Comparing adverse event of similar devices
Correct fitting
Taking and analyzing ocular coherence tomography (OCT) images and slit lamp observations to estimate the clearance
Contact lens wear comfort, as assessed by subject data from questionnaires Rasch analyzed using a 4-Andrich ration scale model
The subjective assessment will be carried out by means of questions on 3 content areas: lens comfort (3 questions), visual quality (4 questions) and general satisfaction with the lenses (3 questions).
Visual acuity assessment and comparison between Designs B (low contrast) and C (high contrast) by means of logMAR or equivalent value
Comparing visual acuity between Designs B and C
Contrast sensitivity assessment and comparison between Designs B (low contrast) and C (high contrast) by means of threshold percentage or equivalent value
Comparing contrast sensitivity between Designs B and C
Horizontal visual angle
Angle at which the volunteer can see his fingers move when extending the arm (same side as dominant eye), 0°=arm extended to the side; 90°=arm straight ahead
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04040790
Brief Title
Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris
Acronym
RGPIRIS_PA
Official Title
Evaluation of Light Sensitivity and Visual Acuity Changes as Consequence of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Terminated
Why Stopped
Several reasons: Financing ended before all study assessments were performed, covid-19 delayed design, production and shipment of IMD, experience gained during the study made it clear that lens design should be changed
Study Start Date
September 16, 2019 (Actual)
Primary Completion Date
June 22, 2021 (Actual)
Study Completion Date
June 22, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Ghent
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Data from 15 healthy subjects will be recorded in two testing sessions spread on two days, using three lens designs (A, B and C). Before the measuring days, each subject will undergo an extra fitting session of a large-diameter scleral contact lens on the dominant eye, assessed by an experienced practitioner. The fitting data will be used to custom-make the three lens designs for each subject, thus ensuring their comfort and safety during the days of the experiments. During the experiment days baseline measurements will be obtained before and after pupil dilation and contact lens wear. During the first testing session data from the lens design A (reference lens without artificial iris) will be recorded. During the second testing session data from the lens designs B and C (lenses with artificial iris with different transmittances) will be recorded. In each testing session, contrast sensitivity and visual acuity will be evaluated and non-invasive imaging measurements will be undertaken (optical coherence tomography and slit lamp). A specific questionnaire will be given to the subject to assess comfort, light sensitivity, the horizontal visual angle and overall experience of the scleral lens and in combination with a pair of sunglasses category 3-4.
Detailed Description
First, the participant will be subjected to an RGP scleral contact lens fitting session, then during the second and third visits the participant will be subjected to several non-invasive procedures specific to the study in order to assess contrast sensitivity and visual acuity using the fitted and uniquely fabricated investigational medical devices. The tests will be performed after eye drops are supplied to dilate the pupil of the subjects (eye drops: tropicamide and phenylephrine). Besides the clinical experiments, the participant will be given a specific questionnaire in order to assess comfort, light sensitivity, horizontal visual angle and overall experience of the investigational medical device and in combination with a pair of sunglasses category 3-4. The investigators will document the occurrence of any adverse events and specific side effects during Day 2 and 3 (testing sessions with the investigational devices) in order to effectively assess their safety.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Vision
Keywords
visual acuity, contrast sensitivity, scleral contact lens, artificial iris
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Healthy volunteers
Arm Type
Experimental
Arm Description
15 healthy volunteers for trials with passive artificial iris
Intervention Type
Device
Intervention Name(s)
Scleral contact lens without a passive artificial iris
Other Intervention Name(s)
Control lens Design A
Intervention Description
Participants wear a scleral contact lens without a passive artificial iris (Design A) on the dominant eye to perform the baseline visual performance assessment
Intervention Type
Device
Intervention Name(s)
Scleral contact lens with a passive artificial iris with low contrast (<1:5)
Other Intervention Name(s)
Test lens Design B
Intervention Description
Participants wear a scleral contact lens with a low contrast (<1:5) passive artificial iris (Design B) on the dominant eye to perform the baseline visual performance assessment
Intervention Type
Device
Intervention Name(s)
Scleral contact lens with a passive artificial iris with high contrast (>1:5)
Intervention Description
Participants wear a scleral contact lens with a low contrast (<1:5) passive artificial iris (Design B) on the dominant eye to perform the baseline visual performance assessment
Intervention Type
Drug
Intervention Name(s)
Tropicamide and phenylephrine
Other Intervention Name(s)
Pupil dilation eye drops
Intervention Description
Participants receive pupil dilation eye drops on the dominant eye, after baseline measurement and before wearing the scleral contact lenses (Designs A, B and C)
Primary Outcome Measure Information:
Title
Visual acuity assessment and comparison between Designs A, B and C by means of logMAR or equivalent value
Description
Compare visual acuity values obtained with different designs
Time Frame
5 months from fitting session
Title
Contrast sensitivity assessment and comparison between Designs A, B and C by means of threshold percentage or equivalent value
Description
Compare contrast sensitivity values obtained with different designs
Time Frame
5 months from fitting session
Secondary Outcome Measure Information:
Title
Device safety by comparing eventual adverse events with those found in scleral contact lenses
Description
Comparing adverse event of similar devices
Time Frame
5 months from fitting session
Title
Correct fitting
Description
Taking and analyzing ocular coherence tomography (OCT) images and slit lamp observations to estimate the clearance
Time Frame
5 months from fitting session
Title
Contact lens wear comfort, as assessed by subject data from questionnaires Rasch analyzed using a 4-Andrich ration scale model
Description
The subjective assessment will be carried out by means of questions on 3 content areas: lens comfort (3 questions), visual quality (4 questions) and general satisfaction with the lenses (3 questions).
Time Frame
5 months from fitting session
Title
Visual acuity assessment and comparison between Designs B (low contrast) and C (high contrast) by means of logMAR or equivalent value
Description
Comparing visual acuity between Designs B and C
Time Frame
5 months from fitting session
Title
Contrast sensitivity assessment and comparison between Designs B (low contrast) and C (high contrast) by means of threshold percentage or equivalent value
Description
Comparing contrast sensitivity between Designs B and C
Time Frame
5 months from fitting session
Title
Horizontal visual angle
Description
Angle at which the volunteer can see his fingers move when extending the arm (same side as dominant eye), 0°=arm extended to the side; 90°=arm straight ahead
Time Frame
5 months from fitting session
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
- Age between 18 and 45 years old
Exclusion Criteria:
Iris disorders (i.e. ocular albinism, coloboma, aniridia).
Known disease-related ocular surface problem (i.e. microbial keratitis).
Known ocular pathologies (except refractive disorders).
Coexistent ocular diseases impeding contact lens correction (i.e. glaucoma, previous ocular surgery).
Corneal scarring.
Low corneal endothelial cell count (< 1500 cells per mm2), with potential of corneal hypoxia-induced corneal edema induced by contact lens wear.
Wearing of contact lenses in the last 24 hours (prior to the interventions).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andres F Vasquez Quintero, Professor
Organizational Affiliation
University Ghent
Official's Role
Study Chair
Facility Information:
Facility Name
University Hospital Ghent (UZGent)
City
Ghent
ZIP/Postal Code
9000
Country
Belgium
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22424803
Citation
Garcia-Lazaro S, Ferrer-Blasco T, Radhakrishnan H, Cervino A, Charman WN, Montes-Mico R. Visual function through 4 contact lens-based pinhole systems for presbyopia. J Cataract Refract Surg. 2012 May;38(5):858-65. doi: 10.1016/j.jcrs.2011.11.042. Epub 2012 Mar 16.
Results Reference
background
PubMed Identifier
23079328
Citation
Pepose JS. Small-aperture contact lenses for presbyopia. J Cataract Refract Surg. 2012 Nov;38(11):2060-1; author reply 2062-4. doi: 10.1016/j.jcrs.2012.08.041. No abstract available.
Results Reference
background
PubMed Identifier
27784070
Citation
Xu R, Gil D, Dibas M, Hare W, Bradley A. The Effect of Light Level and Small Pupils on Presbyopic Reading Performance. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5656-5664. doi: 10.1167/iovs.16-20008.
Results Reference
background
PubMed Identifier
9544648
Citation
Eyeson-Annan ML, Hirst LW, Battistutta D, Green A. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. Ophthalmology. 1998 Apr;105(4):726-32. doi: 10.1016/S0161-6420(98)94030-1.
Results Reference
background
PubMed Identifier
25190661
Citation
Compan V, Oliveira C, Aguilella-Arzo M, Molla S, Peixoto-de-Matos SC, Gonzalez-Meijome JM. Oxygen diffusion and edema with modern scleral rigid gas permeable contact lenses. Invest Ophthalmol Vis Sci. 2014 Sep 4;55(10):6421-9. doi: 10.1167/iovs.14-14038.
Results Reference
background
PubMed Identifier
6592160
Citation
Holden BA, Mertz GW. Critical oxygen levels to avoid corneal edema for daily and extended wear contact lenses. Invest Ophthalmol Vis Sci. 1984 Oct;25(10):1161-7.
Results Reference
background
Learn more about this trial
Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris
We'll reach out to this number within 24 hrs